Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

NYSE: BHVN · IEX Real-Time Price · USD

33.94

+0.28 (0.83%)

Dec 4, 2023, 4:00 PM EST - Market closed

BHVN Stock Forecast

Stock Price Forecast

According to 5 stock analysts, the average 12-month stock price forecast for BHVN stock stock is $29.4, which predicts a decrease of -13.38%. The lowest target is $24 and the highest is $36. On average, analysts rate BHVN stock stock as a strong buy.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$24	$29.4	$31	$36
Change	-29.29%	-13.38%	-8.66%	+6.07%

Analyst Ratings

The average analyst rating for BHVN stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '23	Aug '23	Sep '23	Oct '23	Nov '23	Dec '23
Strong Buy	1	1	1	1	1	1
Buy	4	4	4	4	4	4
Hold	1	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	5	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tessa Romero JP Morgan	JP Morgan	Buy Maintains $26 → $32	Buy	Maintains	$26 → $32	-5.72%	Nov 20, 2023
Christopher Raymond Piper Sandler	Piper Sandler	Buy Maintains $29 → $36	Buy	Maintains	$29 → $36	+6.07%	Nov 15, 2023
Tessa Romero JP Morgan	JP Morgan	Buy Maintains $27 → $24	Buy	Maintains	$27 → $24	-29.29%	Aug 16, 2023
Charles Duncan Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $31	Buy	Reiterates	$31	-8.66%	Jul 17, 2023
Thomas Shrader BTIG	BTIG	Strong Buy Reiterates $24	Strong Buy	Reiterates	$24	-29.29%	Jun 6, 2023

Full Analyst Rating History

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-5.05

from -12.75

EPS Next Year

-3.69

from -5.05

Year	2020	2021	2022	2023	2023	2024	2024	2025	2025	2026	2026	2027	2027	2028	2028
Revenue	-	-	-	-	-	41.19M	21.86M	52.74M	32.51M	185.29M	150.60M	348.72M	391.30M	433.66M	615.18M
Revenue Growth	-	-	-	-	-	-	-46.93%	141.28%	-38.36%	469.97%	-18.72%	131.55%	12.21%	10.83%	41.86%
EPS	-3.01	-5.43	-12.75	-5.05	-3.69	-3.70	-4.94	-5.06	-3.37	-3.93	-1.65	-0.82	-	-	-
EPS Growth	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	9	4	4	9	8	3	3	4	3	6	4	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2023	2024	2025	2026	2027	2028
High	n/a	157.5M	87.5M	291.2M	562.9M	833.8M
Avg	n/a	21.9M	32.5M	150.6M	391.3M	615.2M
Low	n/a	n/a	n/a	24.5M	186.2M	367.5M

Revenue Growth

Revenue Growth	2023	2024	2025	2026	2027	2028
High	-	-	300.2%	795.7%	273.8%	113.1%
Avg	-	-	48.7%	363.3%	159.8%	57.2%
Low	-	-	-	-24.6%	23.6%	-6.1%

EPS Forecast

EPS	2023	2024	2025	2026	2027	2028
High	-3.57	-2.88	-3.47	-4.04	-0.61	-0.84
Avg	-3.69	-4.94	-3.37	-3.93	-1.65	-0.82
Low	-3.77	-6.02	-3.23	-3.77	-2.60	-0.78

EPS Growth

EPS Growth	2023	2024	2025	2026	2027	2028
High	-	-	-	-	-	-
Avg	-	-	-	-	-	-
Low	-	-	-	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.